About This Event
Lexicon Pharmaceuticals (Nasdaq: LXRX), a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives, visits the Nasdaq MarketSite in Times Square to commemorate the Company’s 30th anniversary and three decades of discovering and developing innovative treatment options for people with serious, chronic conditions.
In honor of the occasion, Mike Exton, Ph.D., chief executive officer and director of Lexicon, rings the Closing Bell.
